Exencial Wealth Advisors LLC Sells 145 Shares of Colgate-Palmolive (NYSE:CL)

Exencial Wealth Advisors LLC lowered its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 1.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,674 shares of the company’s stock after selling 145 shares during the quarter. Exencial Wealth Advisors LLC’s holdings in Colgate-Palmolive were worth $1,243,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in CL. Kohmann Bosshard Financial Services LLC bought a new stake in Colgate-Palmolive in the fourth quarter valued at about $26,000. Centricity Wealth Management LLC bought a new stake in Colgate-Palmolive in the fourth quarter valued at about $27,000. Union Bancaire Privee UBP SA bought a new stake in Colgate-Palmolive in the fourth quarter valued at about $32,000. Bernard Wealth Management Corp. bought a new stake in Colgate-Palmolive in the fourth quarter valued at about $36,000. Finally, Roxbury Financial LLC bought a new stake in Colgate-Palmolive in the fourth quarter valued at about $43,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $91.87 on Thursday. The stock has a 50 day moving average price of $88.72 and a 200 day moving average price of $95.27. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock has a market capitalization of $74.56 billion, a PE ratio of 26.10, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm earned $0.87 earnings per share. Analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were paid a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.18%. Colgate-Palmolive’s dividend payout ratio is 56.82%.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of research analyst reports. StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Monday. Stifel Nicolaus decreased their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. Barclays decreased their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. TD Cowen decreased their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus price target of $101.61.

Get Our Latest Analysis on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.